Go Pro
→ A councilman backed AI — then 13 bullets hit his front door (From Stansberry Research) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
$234.29
-4.3%		$234.01
$171.18
▼
$248.84
$25.81B0.55962,273 shs1.37 million shs
Fresenius Medical Care AG & Co. KGaA stock logo
FMS
Fresenius Medical Care AG & Co. KGaA
$22.53
+1.4%		$23.62
$20.02
▼
$27.64
$12.09B0.76684,380 shs314,767 shs
Guardant Health, Inc. stock logo
GH
Guardant Health
$177.61
+2.2%		$161.41
$55.38
▼
$183.51
$23.85B1.572.25 million shs662,084 shs
Labcorp Holdings Inc. stock logo
LH
Labcorp
$312.26
-2.7%		$315.41
$244.52
▼
$341.80
$25.30B0.88684,996 shs451,254 shs
7 Stocks That Could Lead the Next Market Boom Cover
7 Stocks That Could Lead the Next Market Boom

Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
-0.75%+2.96%+0.19%+24.32%+33.28%
Fresenius Medical Care AG & Co. KGaA stock logo
FMS
Fresenius Medical Care AG & Co. KGaA
+0.20%-2.65%-5.04%-6.24%-11.99%
Guardant Health, Inc. stock logo
GH
Guardant Health
-3.07%+3.59%+1.86%+32.90%+193.95%
Labcorp Holdings Inc. stock logo
LH
Labcorp
+0.30%+1.91%-4.39%+24.14%+15.95%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
$234.29
-4.3%		$234.01
$171.18
▼
$248.84
$25.81B0.55962,273 shs1.37 million shs
Fresenius Medical Care AG & Co. KGaA stock logo
FMS
Fresenius Medical Care AG & Co. KGaA
$22.53
+1.4%		$23.62
$20.02
▼
$27.64
$12.09B0.76684,380 shs314,767 shs
Guardant Health, Inc. stock logo
GH
Guardant Health
$177.61
+2.2%		$161.41
$55.38
▼
$183.51
$23.85B1.572.25 million shs662,084 shs
Labcorp Holdings Inc. stock logo
LH
Labcorp
$312.26
-2.7%		$315.41
$244.52
▼
$341.80
$25.30B0.88684,996 shs451,254 shs
7 Stocks That Could Lead the Next Market Boom Cover
7 Stocks That Could Lead the Next Market Boom

Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
-0.75%+2.96%+0.19%+24.32%+33.28%
Fresenius Medical Care AG & Co. KGaA stock logo
FMS
Fresenius Medical Care AG & Co. KGaA
+0.20%-2.65%-5.04%-6.24%-11.99%
Guardant Health, Inc. stock logo
GH
Guardant Health
-3.07%+3.59%+1.86%+32.90%+193.95%
Labcorp Holdings Inc. stock logo
LH
Labcorp
+0.30%+1.91%-4.39%+24.14%+15.95%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
2.54
Moderate Buy$237.081.19% Upside
Fresenius Medical Care AG & Co. KGaA stock logo
FMS
Fresenius Medical Care AG & Co. KGaA
1.55
Reduce$23.574.59% Upside
Guardant Health, Inc. stock logo
GH
Guardant Health
2.96
Moderate Buy$188.135.92% Upside
Labcorp Holdings Inc. stock logo
LH
Labcorp
2.75
Moderate Buy$337.738.16% Upside

Current Analyst Ratings Breakdown

Latest FMS, DGX, LH, and GH Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
9/21/2026
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
Truist Financial Corporation logo
Truist Financial
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetHold$250.00 ➝ $260.00
9/21/2026
Labcorp Holdings Inc. stock logo
LH
Labcorp
Truist Financial Corporation logo
Truist Financial
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$350.00 ➝ $365.00
9/15/2026
Guardant Health, Inc. stock logo
GH
Guardant Health
Piper Sandler logo
Piper Sandler
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOverweight
9/11/2026
Labcorp Holdings Inc. stock logo
LH
Labcorp
UBS Group AG logo
UBS Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$361.00 ➝ $380.00
9/11/2026
Labcorp Holdings Inc. stock logo
LH
Labcorp
Barclays PLC logo
Barclays
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetEqual Weight$320.00 ➝ $330.00
9/10/2026
Guardant Health, Inc. stock logo
GH
Guardant Health
Sanford C. Bernstein logo
Sanford C. Bernstein
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOutperform$210.00
9/9/2026
Guardant Health, Inc. stock logo
GH
Guardant Health
UBS Group AG logo
UBS Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$175.00 ➝ $225.00
9/8/2026
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
UBS Group AG logo
UBS Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetNeutral$232.00 ➝ $245.00
9/8/2026
Guardant Health, Inc. stock logo
GH
Guardant Health
Rothschild & Co Redburn logo
Rothschild & Co Redburn
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageBuy$203.00
9/8/2026
Guardant Health, Inc. stock logo
GH
Guardant Health
Rothschild & Co Redburn logo
Rothschild & Co Redburn
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageBuy$203.00
9/2/2026
Guardant Health, Inc. stock logo
GH
Guardant Health
BTIG Research logo
BTIG Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$195.00
(Data available from 9/22/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
$11.04B2.34$14.43 per share16.24$64.78 per share3.62
Fresenius Medical Care AG & Co. KGaA stock logo
FMS
Fresenius Medical Care AG & Co. KGaA
$22.20B0.55$5.65 per share3.99$28.93 per share0.78
Guardant Health, Inc. stock logo
GH
Guardant Health
$982.02M24.27N/AN/A($0.79) per share-224.82
Labcorp Holdings Inc. stock logo
LH
Labcorp
$13.95B1.82$24.17 per share12.92$103.98 per share3.00
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
$992M$9.4224.8219.572.259.18%16.01%7.27%10/20/2026 (Estimated)
Fresenius Medical Care AG & Co. KGaA stock logo
FMS
Fresenius Medical Care AG & Co. KGaA
$1.11B$1.9311.679.594.124.83%9.28%4.16%11/3/2026 (Estimated)
Guardant Health, Inc. stock logo
GH
Guardant Health
-$416.28M-$3.49N/AN/AN/A-38.33%N/A-25.40%10/28/2026 (Estimated)
Labcorp Holdings Inc. stock logo
LH
Labcorp
$876.50M$12.0925.8015.851.826.99%16.74%7.81%10/27/2026 (Estimated)

Latest FMS, DGX, LH, and GH Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
10/20/2026Q3 2026
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
$2.85N/AN/AN/A$3.04 billionN/A
8/3/2026Q2 2026
Fresenius Medical Care AG & Co. KGaA stock logo
FMS
Fresenius Medical Care AG & Co. KGaA
$0.6160$0.66+$0.0440$0.46$5.48 billion$5.55 billion
7/30/2026Q2 2026
Guardant Health, Inc. stock logo
GH
Guardant Health
-$0.7618-$0.42+$0.3418-$0.90$314.23 million$334.98 million
7/30/2026Q2 2026
Labcorp Holdings Inc. stock logo
LH
Labcorp
$4.78$4.99+$0.21$3.64$3.71 billion$3.73 billion
7/23/2026Q2 2026
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
$2.82$3.12+$0.30$2.84$2.97 billion$3.04 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
$3.441.47%+7.34%36.52%14 Years
Fresenius Medical Care AG & Co. KGaA stock logo
FMS
Fresenius Medical Care AG & Co. KGaA
$0.612.71%+2.66%31.61%N/A
Guardant Health, Inc. stock logo
GH
Guardant Health
N/AN/AN/AN/AN/A
Labcorp Holdings Inc. stock logo
LH
Labcorp
$2.880.92%N/A23.82%N/A

Latest FMS, DGX, LH, and GH Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
8/12/2026
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
quarterly$0.861.45%10/6/202610/6/202610/21/2026
7/9/2026
Labcorp Holdings Inc. stock logo
LH
Labcorp
quarterly$0.720.86%8/28/20268/28/20269/11/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
0.72
1.59
1.46
Fresenius Medical Care AG & Co. KGaA stock logo
FMS
Fresenius Medical Care AG & Co. KGaA
0.43
1.07
0.75
Guardant Health, Inc. stock logo
GH
Guardant Health
N/A
4.03
3.71
Labcorp Holdings Inc. stock logo
LH
Labcorp
0.69
1.80
1.53

Institutional Ownership

CompanyInstitutional Ownership
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
88.06%
Fresenius Medical Care AG & Co. KGaA stock logo
FMS
Fresenius Medical Care AG & Co. KGaA
8.37%
Guardant Health, Inc. stock logo
GH
Guardant Health
92.60%
Labcorp Holdings Inc. stock logo
LH
Labcorp
95.94%

Insider Ownership

CompanyInsider Ownership
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
0.88%
Fresenius Medical Care AG & Co. KGaA stock logo
FMS
Fresenius Medical Care AG & Co. KGaA
N/A
Guardant Health, Inc. stock logo
GH
Guardant Health
5.60%
Labcorp Holdings Inc. stock logo
LH
Labcorp
0.84%
CompanyEmployeesShares OutstandingFree FloatOptionable
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
57,000110.37 million109.40 millionOptionable
Fresenius Medical Care AG & Co. KGaA stock logo
FMS
Fresenius Medical Care AG & Co. KGaA
1,488537.13 millionN/AOptionable
Guardant Health, Inc. stock logo
GH
Guardant Health
2,506134.20 million126.68 millionNot Optionable
Labcorp Holdings Inc. stock logo
LH
Labcorp
71,00081.10 million80.42 millionOptionable

Recent News About These Companies

Labcorp (NYSE:LH) Shares Gap Down - Time to Sell?
 |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/price-labcorp-nyse-lh-shares-gap-down-time-to-sell-2026-09-22/
Baird Adjusts Price Target on Labcorp Holdings to $361 From $352, Maintains Outperform Rating
 |  marketscreener.comM
Quest Diagnostics, Labcorp Shares Fall as Medicare Signals Cuts in Payment Rates for Lab Services
 |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/quest-diagnostics-labcorp-shares-fall-124652405.html
Labcorp stock heads into the open after a 0.1 percent gain
September 22 at 4:17 AM  |  ad-hoc-news.deA
Nykredit A S Buys Shares of 23,785 Labcorp Holdings Inc. $LH
September 22 at 3:20 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-nykredit-a-s-buys-shares-of-23785-labcorp-holdings-inc-lh-2026-09-22/
Truist Financial Issues Positive Forecast for Labcorp (NYSE:LH) Stock Price
September 22 at 1:54 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31037886
Labcorp (NYSE:LH) Stock Price Expected to Rise, Truist Financial Analyst Says
September 21 at 9:17 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/analyst-labcorp-nyse-lh-stock-price-expected-to-rise-truist-financial-analyst-says-2026-09-21/
Labcorp stock holds near recent highs after Q2 2026 earnings beat
September 21 at 7:33 AM  |  ad-hoc-news.deA
Truist Lifts Price Target on Labcorp Holdings to $365 From $350, Keeps Buy Rating
September 21 at 7:33 AM  |  marketscreener.comM
Labcorp (NYSE:LH) Issues FY 2026 Earnings Guidance
September 20 at 7:11 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31035375
Labcorp (NYSE:LH) Updates FY 2026 Earnings Guidance
September 18, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/guidance-labcorp-nyse-lh-updates-fy-2026-earnings-guidance-2026-09-18/
Baird Financial Group Inc. Purchases 5,966 Shares of Labcorp Holdings Inc. $LH
September 17, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-baird-financial-group-inc-purchases-5966-shares-of-labcorp-holdings-inc-lh-2026-09-17/
Labcorp Holdings Inc. (LH) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
September 15, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4946610-labcorp-holdings-inc-lh-presents-at-morgan-stanley-24th-annual-global-healthcare-conference
Labcorp Holdings Inc. $LH Shares Purchased by Tidal Investments LLC
September 13, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-labcorp-holdings-inc-lh-shares-purchased-by-tidal-investments-llc-2026-09-13/
National Pension Service Sells 146,486 Shares of Labcorp Holdings Inc. $LH
September 13, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-national-pension-service-sells-146486-shares-of-labcorp-holdings-inc-lh-2026-09-13/
Labcorp (NYSE:LH) & Surgery Partners (NASDAQ:SGRY) Financial Review
September 13, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31019985
Labcorp Holdings Inc. (LH) Analyst/Investor Day - Slideshow
September 12, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4945809-labcorp-holdings-inc-lh-analyst-investor-day-slideshow
(LH) Labcorp anticipe un bénéfice par action ajusté compris entre 18,10 et 18,55 dollars pour l'exercice 2026
September 12, 2026  |  zonebourse.comZ
Labcorp Holdings Reiterates 2026 Outlook, Issues Long-Term Guidance
September 11, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/labcorp-holdings-reiterates-2026-outlook-112510225.html
Rep. April McClain Delaney Sells Off Labcorp Holdings Inc. (NYSE:LH) Shares
September 11, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/congress-rep-april-mcclain-delaney-sells-off-labcorp-holdings-inc-nyse-lh-shares-2026-09-11/
Rep. April McClain Delaney Sells Labcorp Holdings Inc. (NYSE:LH) Stock
September 11, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/congress-rep-april-mcclain-delaney-sells-labcorp-holdings-inc-nyse-lh-stock-2026-09-11/

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Data center hallway with rows of server racks and cables, plus a monitoring room with computer screens in the background.
AI Token Costs Are Changing the Hardware vs. Software Debate
By Jeffrey Neal Johnson | September 6, 2026
NVIDIA logo over a computer chip, server racks, and an upward-trending green stock price chart.
NVIDIA’s Blockbuster Quarter May Still Undersell How Big the AI Buildout Is
By Thomas Hughes | August 27, 2026
Illustration of a computer chip on a circuit board with an upward green stock chart line in a server room.
Securing AI: 5 Most-Upgraded Stocks From the Q2 Reporting Season
By Thomas Hughes | August 31, 2026
A Tesla concept vehicle with illuminated front light bar drives on a road against a city skyline at dusk.
Tesla’s Robotaxi Launch Wasn’t the Moment Investors Expected
By Sam Quirke | September 8, 2026
A glass cube engraved with "ETF" sits on a wooden desk in a modern office setting.
3 Zero-Fee ETFs Worth More Than Their Cost
By Nathan Reiff | September 18, 2026
Quest Diagnostics stock logo

Quest Diagnostics NYSE:DGX

$234.28 -10.60 (-4.33%)
As of 12:42 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.

Fresenius Medical Care AG & Co. KGaA stock logo

Fresenius Medical Care AG & Co. KGaA NYSE:FMS

$22.53 +0.31 (+1.40%)
As of 12:42 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. It also develops, manufactures, and distributes various health care products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. Fresenius Medical Care AG was incorporated in 1996 and is headquartered in Bad Homburg, Germany.

Guardant Health stock logo

Guardant Health NASDAQ:GH

$177.61 +3.74 (+2.15%)
As of 12:42 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, data sets, and analytics in the United States and internationally. The company provides Guardant360; Guardant360 LDT; Guardant360 CDx Test; Guardant360 Response Test; Guardant360 TissueNext Test; GuardantINFINITY Test; GuardantConnect, an integrated software-based solution designed for clinical and biopharmaceutical customers to connect patients tested with assays with actionable alterations with potentially relevant clinical studies; GuardantOMNI Test for advanced stage cancer; and GuardantINFORM, an in-silico research platform for tumor evolution and treatment resistance across various biomarker-driven cancers. It offers Shield Test; Guardant Reveal Test for adjuvant treatment selection in early-stage cancer patients; Smart Liquid Biopsy Platform; and Guardant Galaxy, an AI-backed digital pathology platform that helps improve cancer biomarker detection. In addition, the company offers development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, technologies licensing, and kits fulfillment. The company has a collaboration agreement with Illumina, Inc. for the sharing of specimen samples to advance cancer research. The company was incorporated in 2011 and is headquartered in Palo Alto, California.

Labcorp stock logo

Labcorp NYSE:LH

$312.26 -8.74 (-2.72%)
As of 12:42 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Labcorp Holdings, Inc. engages in providing medical testing services. The company was founded on April 16, 2024 and is headquartered in Burlington, NC.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas